You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
QDx's RT-PCR-based test is designed to detect the SARS-CoV-2 N gene, while Biocan's immunoassay is designed to detect antibodies against the virus.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.
CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.
Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.
In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.